Pyrroloquinoline quinone modulates YAP-related anti-ferroptotic activity to protect against myocardial hypertrophy

• Auteurs principaux: Jiabin Zhou (Auteur), Tao Yu (Auteur), Gujie Wu (Auteur), Peng Xu (Auteur), Chen Wang (Auteur), Yiling Su (Auteur), Li Wang (Auteur), Qi Lu (Auteur)
• Format: Livre
• Publié: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

Background: Pyrroloquinoline quinone (PQQ) has been reported to exhibit cardioprotective and antioxidant activities. Accordingly, this study was developed to explore the effects of PQQ treatment on myocardial hypertrophy and the underlying mechanism of action governing any observed beneficial effect...